NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Caplight Logo









Shionogi & Co.

Shionogi & Co.

Japanshionogi.com

Overview

Shionogi & Co., Ltd. is a Japanese pharmaceutical company that focuses on the research, development, manufacturing, and marketing of pharmaceutical products, particularly in the areas of infectious diseases, pain/central nervous system (CNS), and cancer. While its primary function is as an operating company, it also engages in strategic investments. In April 2025, the company established a Corporate Venture Capital (CVC) group to invest in seed, early, and mid-stage startups to identify future growth opportunities. The company also acts as a Limited Partner (LP) through investment agreements with venture capital funds like AN Venture Partners.

Portfolio Companies

5

Investments

CompanyDateStageLead
Dioseve Inc.Jun 2026Series A ExtensionLead
AVITA, Inc.Aug 2024Series ACo-investor
LIFESCAPESNov 2022Series C ExtensionCo-investor
Pixie Dust TechnologiesOct 2022Series CCo-investor
AVITA, Inc.Sep 2021SeedCo-investor

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersJapan
Year FoundedN/A

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.





Caplight Logo




Use CasesInvestorsEmployees

CompaniesAll Companies

LegalPrivacy PolicyTerms of UseBrokerCheckForm CRS


Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.